Notify me when Telemetry Investments, L.L.C. files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2022 | 140 | $42,783,000 | +$12,746,731 | -$29,944,929 | -$17,198,198 | SPKB, ATVI, ATYR, TCOA, SHUAU | 13F-HR | 14 Feb 2023, 09:14 |
| Q3 2022 | 173 | $61,037,000 | +$20,168,684 | -$24,093,254 | -$3,924,570 | SPKB, SHLX, ATVI, ATYR, CTXS | 13F-HR | 17 Nov 2022, 10:37 |
| Q2 2022 | 176 | $65,524,000 | +$21,283,510 | -$10,711,251 | +$10,572,259 | SPKB, ATVI, POND, XLE, EIGR | 13F-HR | 15 Aug 2022, 10:44 |
| Q1 2022 | 164 | $62,455,000 | +$25,943,847 | -$36,686,682 | -$10,742,835 | SPKB, XLE, POND, ATVI, EIGR | 13F-HR | 16 May 2022, 08:50 |
| Q4 2021 | 175 | $76,356,000 | +$34,813,887 | -$28,932,316 | +$5,881,571 | IWM, POND, SPKB, XLNX, QQQ | 13F-HR | 14 Feb 2022, 08:38 |
| Q3 2021 | 158 | $71,552,000 | +$33,592,850 | -$30,108,366 | +$3,484,484 | POND, SPKB, HWELU, APACU, XLNX | 13F-HR | 15 Nov 2021, 10:30 |
| Q2 2021 | 138 | $71,794,000 | +$33,218,480 | -$51,422,446 | -$18,203,966 | PONDU, SPKB, ALXN, WORK, XLNX | 13F-HR | 16 Aug 2021, 10:32 |
| Q1 2021 | 126 | $88,452,000 | +$45,535,232 | -$16,533,403 | +$29,001,829 | SPKBU, WTW, RSP, IPHI, WORK | 13F-HR | 17 May 2021, 10:05 |
| Q4 2020 | 83 | $54,429,000 | +$21,183,758 | -$16,523,393 | +$4,660,365 | VAR, WTW, IPHI, XLNX, EIGR | 13F-HR | 16 Feb 2021, 11:05 |
| Q3 2020 | 67 | $42,477,000 | +$14,385,724 | -$5,158,751 | +$9,226,973 | WTW, ETFC, VAR, KDMN, HGEN | 13F-HR | 16 Nov 2020, 09:21 |
| Q2 2020 | 59 | $33,130,000 | +$18,206,624 | -$14,009,091 | +$4,197,533 | KDMN, ETFC, BLPH, REGN, EIGR | 13F-HR | 14 Aug 2020, 12:10 |
| Q1 2020 | 48 | $25,429,000 | +$12,070,031 | -$10,212,042 | +$1,857,989 | AGN, KDMN, ZSAN, LOGM, EIGR | 13F-HR | 15 May 2020, 08:46 |
| Q4 2019 | 40 | $28,634,000 | +$8,111,207 | -$15,840,010 | -$7,728,803 | WCG, AGN, KDMN, DERM, EIGR | 13F-HR | 14 Feb 2020, 10:25 |
| Q3 2019 | 51 | $32,189,000 | +$7,563,117 | -$22,896,888 | -$15,333,771 | CELG, KDMN, EIGR, XTNT, WCG | 13F-HR | 14 Nov 2019, 11:50 |
| Q2 2019 | 67 | $50,048,000 | +$26,583,191 | -$23,069,554 | +$3,513,637 | KDMN, EIGR, XTNT, RHT, WCG | 13F-HR | 14 Aug 2019, 10:49 |
| Q1 2019 | 79 | $49,884,000 | +$17,411,933 | -$47,254,775 | -$29,842,842 | KDMN, DERMIRA INC, IDTI, XTNT, EIGR | 13F-HR | 15 May 2019, 10:16 |
| Q4 2018 | 99 | $74,739,000 | +$44,046,980 | -$25,108,728 | +$18,938,252 | KDMN, XLF, EEM, NOVAVAX INC, RHT | 13F-HR | 14 Feb 2019, 11:18 |
| Q3 2018 | 85 | $67,007,000 | +$25,668,368 | -$41,909,371 | -$16,241,003 | KDMN, PERNIX THERAPEUTICS HLDGS IN, NOVAVAX INC, ACORDA THERAPEUTICS INC, AET | 13F-HR | 14 Nov 2018, 11:47 |
| Q2 2018 | 103 | $83,429,000 | +$35,017,391 | -$44,659,664 | -$9,642,273 | KDMN, SPY, PERNIX THERAPEUTICS HLDGS IN, AET, DERMIRA INC | 13F-HR | 14 Aug 2018, 13:42 |
| Q1 2018 | 107 | $91,637,000 | +$43,647,043 | -$33,565,562 | +$10,081,481 | KDMN, AMAG PHARMACEUTICALS INC, PERNIX THERAPEUTICS HLDGS IN, AET, TWX | 13F-HR | 15 May 2018, 10:59 |
| Q4 2017 | 82 | $78,890,000 | +$26,092,141 | -$42,967,337 | -$16,875,196 | KDMN, AMAG PHARMACEUTICALS INC, TWX, PERNIX THERAPEUTICS HLDGS IN, ACORDA THERAPEUTICS INC | 13F-HR | 14 Feb 2018, 10:53 |
| Q3 2017 | 103 | $97,325,000 | +$42,727,219 | -$35,276,141 | +$7,451,078 | AMAG PHARMACEUTICALS INC, KDMN, PERNIX THERAPEUTICS HLDGS IN, PTC THERAPEUTICS INC, ACORDA THERAPEUTICS INC | 13F-HR | 14 Nov 2017, 12:35 |
| Q2 2017 | 83 | $89,134,000 | +$45,011,274 | -$49,914,724 | -$4,903,450 | AMAG PHARMACEUTICALS INC, KDMN, DEPOMED INC, OREXIGEN THERAPEUTICS INC, ACORDA THERAPEUTICS INC | 13F-HR | 14 Aug 2017, 12:07 |
| Q1 2017 | 87 | $89,524,000 | +$46,778,925 | -$31,581,649 | +$15,197,276 | ACORDA THERAPEUTICS INC, SUCAMPO PHARMACEUTICALS INC, OREXIGEN THERAPEUTICS INC, KDMN, PDL BIOPHARMA INC | 13F-HR | 15 May 2017, 11:27 |
| Q4 2016 | 85 | $74,724,000 | +$29,454,188 | -$43,992,474 | -$14,538,286 | ACORDA THERAPEUTICS INC, MON, AEGERION PHARMACEUTICALS INC, HUM, PTC THERAPEUTICS INC | 13F-HR | 14 Feb 2017, 12:04 |
| Q3 2016 | 96 | $87,308,000 | +$38,111,366 | -$46,451,491 | -$8,340,125 | LNKD, HUM, AEGERION PHARMACEUTICALS INC, ACORDA THERAPEUTICS INC, PTC THERAPEUTICS INC | 13F-HR | 14 Nov 2016, 11:30 |
| Q2 2016 | 102 | $92,468,000 | +$32,783,015 | -$50,173,675 | -$17,390,660 | HUM, SEQUENOM INC, AEGERION PHARMACEUTICALS INC, IOC, SPECTRANETICS CORP | 13F-HR | 15 Aug 2016, 13:56 |
| Q1 2016 | 92 | $111,605,000 | +$41,294,726 | -$77,393,645 | -$36,098,919 | HUM, AGN, TWC, SEQUENOM INC, CLOVIS ONCOLOGY INC | 13F-HR | 16 May 2016, 12:50 |
| Q4 2015 | 114 | $157,375,000 | +$62,484,558 | -$83,189,400 | -$20,704,842 | AEGERION PHARMACEUTICALS INC, CLOVIS ONCOLOGY INC, PCP, COBALT INTL ENERGY INC, SEQUENOM INC | 13F-HR | 16 Feb 2016, 10:19 |
| Q3 2015 | 108 | $180,422,000 | +$103,433,495 | -$67,733,660 | +$35,699,835 | EEM, OREXIGEN THERAPEUTICS INC, COBALT INTL ENERGY INC, FEZ, EXELIXIS INC | 13F-HR | 16 Nov 2015, 11:35 |
| Q2 2015 | 157 | $157,749,000 | +$87,568,595 | -$62,872,685 | +$24,695,910 | COBALT INTL ENERGY INC, OREXIGEN THERAPEUTICS INC, EXELIXIS INC, FDO, IOC | 13F-HR | 14 Aug 2015, 09:56 |
| Q1 2015 | 180 | $133,567,000 | +$76,040,212 | -$84,942,706 | -$8,902,494 | EXELIXIS INC, IOC, COBALT INTL ENERGY INC, ACORDA THERAPEUTICS INC, SLXP | 13F-HR | 15 May 2015, 14:22 |
| Q4 2014 | 156 | $138,168,000 | $0 | $0 | $0 | FEZ, COBALT INTL ENERGY INC, F113PS, EXELIXIS INC, IOC | 13F-HR | 22 Apr 2015, 15:27 |